Ozempic-style medications have been endorsed as long-term treatments for obesity under new guidelines released by the World ...

Eli Lilly has cut cash prices for its weight-loss drug Zepbound on LillyDirect, lowering monthly costs to $299–$449. The move ...

In today’s ACT Brief, we examine how the CRA role is transforming alongside modern clinical trial technology, review the ...

The World Health Organization has released new guidance on some weight loss medications for adults with obesity.

If you're using one of the GLP-1 drugs for weight loss, like Ozempic or Wegovy, you might be tempted to skip your dose to ...

Eli Lilly has lowered the price of its GLP-1 drug Zepbound (tirzepatide) in single-dose vials, with the starting dose now available for $299 per month through the company’s direct-to-consumer platform ...

Amy Schumer has never shied away from speaking about her health journey over the years, particularly when it comes to her ...

The World Health Organization is officially backing popular weight-loss drugs like Ozempic and Wegovy. The WHO published new guidelines about glucagon-like peptide-1 (GLP-1) medications in the medical ...

The Australian medicines regulator has issued a mental health safety warning for a drug widely used for weight loss.

In today’s Pharmaceutical Executive Daily, Novo Nordisk files for FDA approval of a higher-dose Wegovy injectable using a ...

Eli Lilly reduced Zepbound vial prices for self-paying patients via LillyDirect, aiming to lower obesity treatment costs and ...